CORMORANT ASSET MANAGEMENT, LP – Mirati Therapeutics, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$40.15M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
+4.04%
quarter
Mirati Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +91.67% | 275K shares | 20.01M | $69.84 | 575K |
| Q2 2022 | share | Increase | +500.00% | 250K shares | 16.02M | $67.13 | 300K |
| Q1 2022 | share | Decrease | -33.33% | -25K shares | -6.89M | $82.22 | 50K |
| Q4 2021 | share | Decrease | -37.50% | -45K shares | -10.22M | $148.23 | 75K |
| Q3 2021 | share | Decrease | -31.43% | -55K shares | -7.03M | $176.91 | 120K |
| Q2 2021 | share | Decrease | -36.36% | -100K shares | -18.84M | $161.53 | 175K |
| Q1 2021 | share | Decrease | -15.38% | -50K shares | -24.27M | $171.3 | 275K |
| Q4 2020 | share | Increase | +18.18% | 50K shares | 25.71M | $219.64 | 325K |
| Q3 2020 | share | Decrease | -45.00% | -225K shares | -11.42M | $166.05 | 275K |
| Q2 2020 | call | Decrease | -100.00% | -500K shares | -38.43M | $114.17 | 0 |
| Q2 2020 | share | Decrease | -41.18% | -350K shares | -8.25M | $114.17 | 500K |
| Q1 2020 | share | Decrease | -33.72% | -432.39K shares | -99.90M | $76.87 | 850K |
| Q1 2020 | call | 0.00% | 0 shares | -25.99M | $76.87 | 500K | |
| Q4 2019 | call | Increase | +150.00% | 300K shares | 48.84M | $128.86 | 500K |
| Q4 2019 | put | Decrease | -100.00% | -550K shares | -42.85M | $128.86 | 0 |
| Q4 2019 | share | Decrease | -19.85% | -317.60K shares | 40.59M | $128.86 | 1.28M |
| Q3 2019 | put | Increase | 0.00% | 550K shares | 42.85M | $77.91 | 550K |
| Q3 2019 | share | Increase | +45.45% | 500K shares | 11.35M | $77.91 | 1.6M |
| Q3 2019 | call | 0.00% | 0 shares | -5.01M | $77.91 | 200K | |
| Q2 2019 | call | Increase | 0.00% | 200K shares | 20.6M | $103 | 200K |
| Q2 2019 | share | Increase | +2.33% | 25K shares | 34.50M | $103 | 1.1M |
| Q1 2019 | share | Decrease | -38.63% | -676.69K shares | 4.49M | $73.3 | 1.07M |
| Q4 2018 | share | Decrease | -3.22% | -58.30K shares | -10.94M | $42.42 | 1.75M |
| Q3 2018 | share | Decrease | -5.65% | -108.35K shares | -9.32M | $47.1 | 1.81M |
| Q2 2018 | share | 0.00% | 0 shares | 35.68M | $49.3 | 1.91M | |
| Q1 2018 | share | Increase | +55.77% | 686.82K shares | 36.41M | $30.7 | 1.91M |
| Q4 2017 | share | Increase | +23.15% | 231.52K shares | 10.77M | $18.25 | 1.23M |
| Q3 2017 | share | Increase | 0.00% | 1M shares | 11.7M | $11.7 | 1M |
| Q2 2016 | share | Decrease | -100.00% | -495.35K shares | -10.60M | $5.46 | 0 |
| Q1 2016 | share | 0.00% | 0 shares | -5.05M | $21.4 | 495.35K |